Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?

Oncology (Williston Park). 2009 Jun;23(7):592, 600, 603.
No abstract available

Publication types

  • Comment

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Neoplasm Staging
  • Risk Factors
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / therapy*